These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
134 related articles for article (PubMed ID: 12473659)
1. Intracellular localization of keratinocyte Fas ligand explains lack of cytolytic activity under physiological conditions. Viard-Leveugle I; Bullani RR; Meda P; Micheau O; Limat A; Saurat JH; Tschopp J; French LE J Biol Chem; 2003 May; 278(18):16183-8. PubMed ID: 12473659 [TBL] [Abstract][Full Text] [Related]
2. Pathways involved in proliferating, senescent and immortalized keratinocyte cell death mediated by two different TRAIL preparations. Qin JZ; Bacon PE; Chaturvedi V; Bonish B; Nickoloff BJ Exp Dermatol; 2002 Dec; 11(6):573-83. PubMed ID: 12473065 [TBL] [Abstract][Full Text] [Related]
3. Crosstalk between keratinocytes and T lymphocytes via Fas/Fas ligand interaction: modulation by cytokines. Arnold R; Seifert M; Asadullah K; Volk HD J Immunol; 1999 Jun; 162(12):7140-7. PubMed ID: 10358159 [TBL] [Abstract][Full Text] [Related]
4. Expression of dominant-negative Fas-associated death domain blocks human keratinocyte apoptosis and vesication induced by sulfur mustard. Rosenthal DS; Velena A; Chou FP; Schlegel R; Ray R; Benton B; Anderson D; Smith WJ; Simbulan-Rosenthal CM J Biol Chem; 2003 Mar; 278(10):8531-40. PubMed ID: 12482751 [TBL] [Abstract][Full Text] [Related]
5. Fas/Fas ligand interaction contributes to UV-induced apoptosis in human keratinocytes. Leverkus M; Yaar M; Gilchrest BA Exp Cell Res; 1997 May; 232(2):255-62. PubMed ID: 9168800 [TBL] [Abstract][Full Text] [Related]
6. FasL and TRAIL induce epidermal apoptosis and skin ulceration upon exposure to Leishmania major. Eidsmo L; Fluur C; Rethi B; Eriksson Ygberg S; Ruffin N; De Milito A; Akuffo H; Chiodi F Am J Pathol; 2007 Jan; 170(1):227-39. PubMed ID: 17200196 [TBL] [Abstract][Full Text] [Related]
7. Possible role of Fas/Fas ligand-mediated apoptosis in the pathogenesis of fixed drug eruption. Choi HJ; Ku JK; Kim MY; Kang H; Cho SH; Kim HO; Park YM Br J Dermatol; 2006 Mar; 154(3):419-25. PubMed ID: 16445769 [TBL] [Abstract][Full Text] [Related]
8. Fas ligand in pemphigus sera induces keratinocyte apoptosis through the activation of caspase-8. Puviani M; Marconi A; Cozzani E; Pincelli C J Invest Dermatol; 2003 Jan; 120(1):164-7. PubMed ID: 12535213 [TBL] [Abstract][Full Text] [Related]
9. Acquisition of granzyme B and Fas ligand proteins by human keratinocytes contributes to epidermal cell defense. Berthou C; Michel L; Soulié A; Jean-Louis F; Flageul B; Dubertret L; Sigaux F; Zhang Y; Sasportes M J Immunol; 1997 Dec; 159(11):5293-300. PubMed ID: 9548468 [TBL] [Abstract][Full Text] [Related]
10. Toxic epidermal necrolysis and Stevens-Johnson syndrome are induced by soluble Fas ligand. Abe R; Shimizu T; Shibaki A; Nakamura H; Watanabe H; Shimizu H Am J Pathol; 2003 May; 162(5):1515-20. PubMed ID: 12707034 [TBL] [Abstract][Full Text] [Related]
11. The mycotoxin penicillic acid inhibits Fas ligand-induced apoptosis by blocking self-processing of caspase-8 in death-inducing signaling complex. Bando M; Hasegawa M; Tsuboi Y; Miyake Y; Shiina M; Ito M; Handa H; Nagai K; Kataoka T J Biol Chem; 2003 Feb; 278(8):5786-93. PubMed ID: 12482880 [TBL] [Abstract][Full Text] [Related]
12. TNF-α and IFN-γ are potential inducers of Fas-mediated keratinocyte apoptosis through activation of inducible nitric oxide synthase in toxic epidermal necrolysis. Viard-Leveugle I; Gaide O; Jankovic D; Feldmeyer L; Kerl K; Pickard C; Roques S; Friedmann PS; Contassot E; French LE J Invest Dermatol; 2013 Feb; 133(2):489-98. PubMed ID: 22992806 [TBL] [Abstract][Full Text] [Related]
13. Fas ligand elicits a caspase-independent proinflammatory response in human keratinocytes: implications for dermatitis. Farley SM; Dotson AD; Purdy DE; Sundholm AJ; Schneider P; Magun BE; Iordanov MS J Invest Dermatol; 2006 Nov; 126(11):2438-51. PubMed ID: 16858424 [TBL] [Abstract][Full Text] [Related]
14. Fas/Fas ligand mediates keratinocyte death in sunitinib-induced hand-foot skin reaction. Yeh CN; Chung WH; Su SC; Chen YY; Cheng CT; Lin YL; Chang WC; Chung-Yee Hui R; Chiang KC; Chen TW; Jan YY; Chen CW; Chen TJ; Yang CH; Hung SI J Invest Dermatol; 2014 Nov; 134(11):2768-2775. PubMed ID: 24802849 [TBL] [Abstract][Full Text] [Related]
15. Fas ligand is expressed on human squamous cell carcinomas of the head and neck, and it promotes apoptosis of T lymphocytes. Gastman BR; Atarshi Y; Reichert TE; Saito T; Balkir L; Rabinowich H; Whiteside TL Cancer Res; 1999 Oct; 59(20):5356-64. PubMed ID: 10537320 [TBL] [Abstract][Full Text] [Related]
16. Expression of membrane-bound and soluble FasL in Fas- and FADD-dependent T lymphocyte apoptosis induced by mildly oxidized LDL. Alcouffe J; Therville N; Ségui B; Nazzal D; Blaes N; Salvayre R; Thomsen M; Benoist H FASEB J; 2004 Jan; 18(1):122-4. PubMed ID: 14630709 [TBL] [Abstract][Full Text] [Related]
17. Keratinocytes constitutively express the CD95 ligand molecule on the plasma membrane: an in situ immunoelectron microscopy study on ultracryosections of normal human skin. de Panfilis G; Semenza D; Lavazza A; Mulder AA; Mommaas AM; Pasolini G Br J Dermatol; 2002 Jul; 147(1):7-12. PubMed ID: 12100178 [TBL] [Abstract][Full Text] [Related]
18. Fas ligand-induced proinflammatory transcriptional responses in reconstructed human epidermis. Recruitment of the epidermal growth factor receptor and activation of MAP kinases. Farley SM; Purdy DE; Ryabinina OP; Schneider P; Magun BE; Iordanov MS J Biol Chem; 2008 Jan; 283(2):919-28. PubMed ID: 17977827 [TBL] [Abstract][Full Text] [Related]
19. Up-regulation of Fas (APO-1/CD95) ligand and down-regulation of Fas expression in human esophageal cancer. Gratas C; Tohma Y; Barnas C; Taniere P; Hainaut P; Ohgaki H Cancer Res; 1998 May; 58(10):2057-62. PubMed ID: 9605741 [TBL] [Abstract][Full Text] [Related]
20. Expression of Fas ligand and its receptor in cutaneous lupus: implication in tissue injury. Nakajima M; Nakajima A; Kayagaki N; Honda M; Yagita H; Okumura K Clin Immunol Immunopathol; 1997 Jun; 83(3):223-9. PubMed ID: 9175910 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]